OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Amazon vs. Costco: Which Stock Is a Better Buy?

Amazon vs. Costco: Which Stock Is a Better Buy?

Cross Staff Loads Up on 289,000 Shares of AKRE

Cross Staff Loads Up on 289,000 Shares of AKRE

Prediction: This Artificial Intelligence (AI) Stock Will Join Nvidia, Apple, and Alphabet in the $3 Trillion Club Before 2028

The billion-dollar infrastructure deals powering the AI boom

AI Boom May Be Creating Hidden Risks In Housing Market

Cisco’s Secure AI Factory Links Sovereign Data Push To Valuation Story

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold 

November 7, 2024

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023. Read...

3rdPartyFeeds

Warner Bros. Discovery adds 7.2 million Max subscribers, the streamer’s largest single-quarter jump

November 7, 2024

Warner Bros. Discovery said its streaming platform Max added 7.2 million subscribers during the third quarter. Read more...

3rdPartyFeeds

NVIDIA Corporation (NVDA) Launches AI Blueprint for Video Search and Summarization, Expanding Generative AI Capabilities for Developers

November 7, 2024

We recently compiled a list of the 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands...

3rdPartyFeeds

Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis

November 7, 2024

SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a...

3rdPartyFeeds

Meet the Supercharged Growth Stock That Could Make You a Millionaire

November 7, 2024

This stock made investors millionaires in the past, and it could still find a place in a million-dollar portfolio. Read More...

3rdPartyFeeds

3 Breakthrough Stocks Leading the Next Tech Revolution

November 7, 2024

These emerging technology pioneers are transforming quantum computing, space intelligence, and urban mobility with market-disrupting innovations. Read More...

3rdPartyFeeds

Adyen shares slide as payments giant’s transaction volume growth slows

November 7, 2024

Adyen shares sank Thursday after the company reported a slowdown in the growth of its transaction volumes in the third quarter. Read more...

3rdPartyFeeds

Lyft forms multiple autonomous driving partnerships

November 7, 2024

Lyft's collaboration with Intel-backed Mobileye will enable the rideshare platform to accommodate vehicles equipped with Mobileye's autonomous technology. Read...

3rdPartyFeeds

Is the Dow Jones Industrial Average Going to Plunge? History Offers a Potentially Worrisome Tale.

November 7, 2024

The historic addition of artificial intelligence (AI) colossus Nvidia may spell trouble for Wall Street's most iconic index. Read More...

3rdPartyFeeds

Investors expect an antitrust ‘sea change’ under Trump. Legal experts aren’t so sure.

November 7, 2024

Investors are cheering the end of an aggressive era of antitrust enforcement now that Donald Trump is returning to the White House. But some legal experts...

Previous 1 … 413 414 415 416 417 … 8,454 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.